![Für diesen Artikel ist leider kein Bild verfügbar.](/img/platzhalter480px.png)
Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice
Oncology Nursing Society (Verlag)
978-1-63593-055-9 (ISBN)
The Oncology Nursing Society's Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) provides nurses with the tools to understand how medications are used in cancer treatment, the effect of medication-related toxicities, and evidence-based recommendations to manage and treat these toxicities. This edition features many new cancer therapies approved since the 2019 publication. Extensive drug tables provide nurses with categorical drug information based on treatment type and tips for managing patients receiving these treatments.
New evidence relating to cancer nursing care is incorporated into this edition, such as hypersensitivity response, safe handling of hazardous drugs, and more. Expanded content on genomics corresponds with the progress made toward personalized oncology. Health equity is approached with information discussing financial distress, cultural disparities, and health literacy. The latest guidelines and recommendations for treatment, symptom management, and survivorship are also included. A QR code is provided with the purchase of this book, allowing access to periodic drug updates.
MiKaela Olsen, DNP, APRN-CNS, AOCNS®, FAAN, is the Clinical Program Director for Oncology at the Johns Hopkins Hospital and the Johns Hopkins Health System. Dr. Olsen works work closely with oncology nurse leaders, oncology physician leaders, and clinical staff to ensure best practice and streamlined coordination of care. Dr. Olsen is coeditor of the Oncology Nursing Society publication Safe Handling of Hazardous Drugs Guidelines and has been the lead editor for both editions of Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice. She also served as lead editor of Hematologic Malignancies in Adults, the first nursing textbook published to guide nurses in the care of hematologic malignancy patients. Kristine B. LeFebvre, MSN, RN, NPD-BC, AOCN®, joined the Oncology Nursing Society in 2004. In the role of Oncology Clinical Specialist, she works on a variety of educational and collaborative projects, including the ASCO/ONS Chemotherapy Administration Safety Standards, ONS Guidelines, educational courses and activities, and global initiatives. Dr. LeFebvre has more than 35 years of oncology nursing experience, including the roles of staff nurse, nurse manager, and clinical nurse specialist in oncology and stem cell transplant.
Erscheinungsdatum | 14.03.2023 |
---|---|
Verlagsort | Pittsburgh |
Sprache | englisch |
Maße | 216 x 280 mm |
Gewicht | 1134 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Medizin / Pharmazie ► Pflege ► Fachpflege | |
ISBN-10 | 1-63593-055-3 / 1635930553 |
ISBN-13 | 978-1-63593-055-9 / 9781635930559 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich